FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and is intended for application as eye drops, nasal drops and ear drops. A liquid pharmaceutical antimicrobial composition contains (7-(3-amino-1-pyrrolodinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthiridin-3-carboxylic acid or its salt, 12-hydrate of aluminiumpotassiumsulphate, borax (sodium tetraborate), sodium chloride and from 0.03% to 0.1% of ethylparahydrozybenzoate.
EFFECT: invention provides high stability, high preserving and pollution-preventing activity.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-BASED LIQUID COMPOSITION WITH BROMFENAC POSSESSING PRESERVATIVE EFFECTIVENESS | 2012 |
|
RU2625755C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING DORSOLAMIDE AND BRIMONIDINE | 2017 |
|
RU2745317C2 |
| DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ZINC | 2014 |
|
RU2675813C2 |
| DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ANTIMICROBIAL METAL | 2014 |
|
RU2666961C2 |
| CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION | 2018 |
|
RU2759901C2 |
| FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
| LIQUID AQUEOUS OPHTHALMIC COMPOSITION | 2007 |
|
RU2445950C2 |
| COMPOSITION OF AN AQUEOUS SUSPENSION COMPRISING NANOPARTICLES OF MACROLIDE ANTIBIOTICS | 2014 |
|
RU2707748C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE, FOR NASAL INTRODUCTION | 2011 |
|
RU2563115C2 |
| COMPOSITION | 2006 |
|
RU2398587C2 |
